[Federal Register Volume 59, Number 105 (Thursday, June 2, 1994)]
[Unknown Section]
[Page 0]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 94-13376]


[[Page Unknown]]

[Federal Register: June 2, 1994]


=======================================================================
-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention

 

Advisory Committee on Immunization Practices; Meeting

    In accordance with section 10(a)(2) of the Federal Advisory 
Committee Act (Pub. L. 92-463), the Centers for Disease Control and 
Prevention (CDC) announces the following committee meeting:

    Name: Advisory Committee on Immunization Practices.
    Times and Dates: 8:30 a.m.-5 p.m., June 29, 1994; 8:30 a.m.-
12:45 p.m., June 30, 1994.
    Place: CDC, Auditorium A, Building 2, 1600 Clifton Road, NE, 
Atlanta, Georgia 30333.
    Status: Open to the public, limited only by the space available.
    Purpose: The committee is charged with advising the Director, 
CDC, on the appropriate uses of immunizing agents.
    Matters To Be Discussed: The committee will discuss 
implementation of the ``Vaccines for Children Program''; the scope 
of the ``Vaccines for Children Program,'' including specific wording 
for hepatitis B, second dose Measles, Mumps, Rubella (MMR) and MMR 
catch-up, and influenza and pneumococcal vaccines for high-risk 
children; ``Vaccines for Children Program'': Other issues and 
statement; status of simplification of vaccine schedule; adolescent 
immunizations; Institute of Medicine report on vaccine safety, DTP 
and chronic encephalopathy, and other vaccines; proposed hepatitis A 
statement; hepatitis C; revised hepatitis B recommendation; revision 
of the varicella statement and status of application for licensure; 
revision of polio vaccine recommendation; BCG update; cost benefit 
analysis of rotavirus vaccines; National Vaccine Advisory 
Committee--adult immunization; an update on the National Vaccine 
Program; and an update on the Injury Compensation Program. Other 
matters of relevance among the committee's objectives may be 
discussed.

    Agenda items are subject to change as priorities dictate.

CONTACT PERSON FOR MORE INFORMATION: Gloria A. Kovach, Committee 
Management Specialist, CDC (1-B72), 1600 Clifton Road NE., Mailstop 
A20, Atlanta, Georgia 30333, telephone 404/639-3851.

    Dated: May 25, 1994.
William H. Gimson,
Acting Associate Director for Policy Coordination, Centers for Disease 
Control and Prevention (CDC).
[FR Doc. 94-13376 Filed 6-1-94; 8:45 am]
BILLING CODE 4163-18-M